 | • レポートコード：STR-DC021 • 出版社/出版日：Straits Research / 2019年11月28日 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ技術 |
| Single User（1名様用、印刷不可） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Multi User（5名様用） | ￥836,200 (USD5,650) | ▷ お問い合わせ |
| Enterprise Price（法人閲覧用） | ￥1,073,000 (USD7,250) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートでは、ウシ胎児血清の世界市場について調査・分析し、調査手法、市場概要、製品別（チャコールストリッピング、クロマトグラフィー、透析ウシ胎児血清（FBS）、エキソソーム枯渇、幹細胞、その他）分析、エンドユーザー別（研究機関、産業）分析、用途別（創薬、細胞培養培地、体外受精、ヒト＆動物用ワクチン生産、診断、その他）分析、地域別分析、企業概要などを含め次の構成でお届け致します。 ・イントロダクション ・調査手法 ・市場概要 ・ウシ胎児血清の世界市場：製品別（チャコールストリッピング、クロマトグラフィー、透析ウシ胎児血清（FBS）、エキソソーム枯渇、幹細胞、その他） ・ウシ胎児血清の世界市場：エンドユーザー別（研究機関、産業） ・ウシ胎児血清の世界市場：用途別（創薬、細胞培養培地、体外受精、ヒト＆動物用ワクチン生産、診断、その他） ・ウシ胎児血清の世界市場：地域別 ・企業概要 |
Global fetal bovine serum market accounted for over USD 731.6 million in 2017 and is expected to grow at a CAGR of 8.2% during the forecast period 2019–2026.
A fetal bovine serum (FBS) is the liquid fraction extracted from a fetal calves, depleted cells, fibrin and clotting factors. FBS contains a large number of nutritional and macromolecular factors which are essential for cell growth. It is primarily used in eukaryotic cell culture, in which it provides several essential nutrients and growth factors which facilitate cell survival and proliferation.
Growing initiatives in research and development by the government and private sector specifically in drug development of both private and government entities and increasing prevalence of several chronic diseases and rare diseases are the vital factors driving the market. According to the U.S. Food & Drug Association (FDA), in low and middle income countries around 70% of deaths occurs due to cancer. Moreover, cancer is the leading cause for death worldwide accounting around 9.6 million deaths in 2018.
Rapid technological advacements in emerging countries such as India, and China and vast technological advancements in the field of fetal bovine serums in developed nations are contributing significantly to the market growth.
Segmental Insights
The global fetal bovine serums market is segmented by product, end-users, temperature range, and region.
By product, the market is segmented into charcoal stripped, chromatographic, dialyzed fetal bovine serum (FBS), exosome depleted, stem cell and others. Stem cell is further segmented into embryonic stem cells qualified and mesenchymal stem cell qualified.
Based on application, fetal bovine serums market is segmented into drug discovery, cell culture media, in vitro fertilization, human and animal vaccine production, diagnostics, others. Drug discovery and cell culture media are expected to grow at the fastest CAGR owing to the increasing cell culture applications and increasing prevalence of rare and chronic diseases.
By end-users, the fetal bovine serums market is segmented into research & academic institutes and industry. The industry is further segmented into pharma, biotech and other industry. The industry segment is expected to register highest CAGR during the forecast period 2019–2026 on account of increasing demand for fetal bovine serum from pharmaceutical and biotechnology industry.
Key Findings
Regional Insights
Geographically, the global Fetal Bovine Serums market is segmented into four regions: North America, Europe, Asia Pacific, and Latin America and the Middle East & Africa (LAMEA).
North America is likely to dominate the fetal bovine serum market. It is expected to witness significant growth owing to highly developed economies and availability of superior technology. Fetal bovine serums are widely used to insulate infrastructures used for storage of volatile chemicals, and high volume of chemical trading, especially in the U.S. is expected to provide a significant boost to the Fetal Bovine Serums sector. For instance, in 2016, the U.S. exported chemicals to Canada, Mexico, China, Belgium, and Brazil, which valued at USD 20 billion, USD 19 billion, USD 10 billion, USD 7 billion, and USD 6 billion respectively.
Europe is likely to emerge as the second largest fetal bovine serums market globally. This can be attributed to the significant presence of pharmaceutical and biotech manufacturers such as Daimler, Volkswagen, and Jaguar in the region.
Asia Pacific is likely to emerge as the fastest growing region for fetal bovine serum market due to growing population and rising industrialization in various economies such as China, India, Japan, and South Korea.
LAMEA is expected to witness steady growth in the healthcare industrial sector. As per the report by the United Nations (UN), there have been significant and heavy investments in the healthcare industrial sector in countries such as Argentina, Brazil, and South Africa.
Key Players:
Some of the key players in the global Fetal Bovine Serums market are Thermo Fisher Scientific Inc., Merck KGaA, Atlanta Biologicals Inc., Tissue Culture Biologicals, HiMedia Laboratories, Bovogen Biologicals Pty Ltd., TCS Biosciences Ltd., Rocky Mountain Biologicals, GE Healthcare, and PAN-Biotech.
What will be the Future Developments in Fetal Bovine Serums Market?
Our Report Covers
• Historical inferences, findings & analysis of the market from 2016 to 2018
• Projections and performance forecast analysis for the future from 2019 to 2026
• Production and consumption point of view (POV) analysis
• Market drivers, restraint and opportunity analysis, to define market dynamics covering industry, regulatory, innovation, technological & pricing trends
• Comprehensive competitive landscape mapping with recent development covering market leadership, competency, sustainability, and prospects
TABLE OF CONTENTS
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: Fetal bovine serum Market
3.3 Key Market Trends
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
3.5 Market Share Analysis
4 Product Overview
4.1 Introduction
4.1.1 Market Size & Forecast (Value & Volume)
4.2 Charcoal Stripped
4.2.1 Market Size & Forecast (Value & Volume)
4.3 Chromatographic
4.3.1 Market Size & Forecast (Value & Volume)
4.4 Dialyzed Fetal Bovine Serum (FBS)
4.4.1 Market Size & Forecast (Value & Volume)
4.5 Exosome Depleted
4.5.1 Market Size & Forecast (Value & Volume)
4.6 Stem Cell
4.6.1 Market Size & Forecast (Value & Volume)
4.6.2 Embryonic Stem Cells Qualified
4.6.3 Mesenchymal Stem Cell Qualified
4.6 Others
5 End-user Overview
5.1 Introduction
5.1.1 Market Size & Forecast (Value & Volume)
5.2 Research & Academic Institutes
5.2.1 Market Size & Forecast (Value & Volume)
5.3 Industry
5.3.1 Market Size & Forecast (Value & Volume)
5.3.2 Pharmaceutical industry
5.3.3 Biotechnological industry
6 Application Overview
6.1 Introduction
6.1.1 Market Size & Forecast (Value & Volume)
6.2 Drug Discovery
6.2.1 Market Size & Forecast (Value & Volume)
6.3 Cell Culture Media
6.3.1 Market Size & Forecast (Value & Volume)
6.4 In vitro Fertilization
6.4.1 Market Size & Forecast (Value & Volume)
6.5 Human and Animal Vaccine production
6.5.1 Market Size & Forecast (Value & Volume)
6.6 Diagnostics
6.6.1 Market Size & Forecast (Value & Volume)
6.7 Others
6.7.1 Market Size & Forecast (Value & Volume)
7 Regional Overview
7.1 Introduction
7.1.1 Market Size & Forecast (Value & Volume)
7.2 America
7.2.1 North America
7.2.1.1 U.S.
7.2.1.1.1 By Product
7.2.1.1.2 By Application
7.2.1.2 Canada
7.2.1.2.1 By Product
7.2.1.2.2 By Application
7.2.1.3 Mexico
7.2.1.3.1 By Product
7.2.1.3.2 By Application
7.2.4 Latin America
7.2.4.1 By Product
7.2.4.2 By Application
7.3 Europe
7.3.1 Market Size & Forecast (Value & Volume)
7.3.2 Germany
7.3.2.1.1 By Product
7.3.2.1.2 By Application
7.3.3 France
7.3.3.1.1 By Product
7.3.3.1.2 By Application
7.3. 4 U.K
7.3.4.1.1 By Product
7.3.4.1.2 By Application
7.3.5 Italy
7.3.5.1.1 By Product
7.3.5.1.2 By Application
7.3.6 Spain
7.3.6.1.1 By Product
7.3.6.1.2 By Application
7.3.7 Rest of Europe
7.3.7.1.1 By Product
7.3.7.1.2 By Application
6.4 Asia Pacific
6.4.1 Market Size & Forecast (Value & Volume)
6.4.2 Japan
6.4.2.1.1 By Product
6.4.2.1.2 By Application
6.4.3 China
6.4.3.1.1 By Product
6.4.3.1.2 By Application
6.4.4 Australia
6.4.4.1.1 By Product
6.4.4.1.2 By Application
6.4.5 India
6.4.5.1.1 By Product
6.4.5.1.2 By Application
6.4.6 South Korea
6.4.6.1.1 By Product
6.4.6.1.2 By Application
6.4.7 Rest of Asia-Pacific
6.4.7.1.1 By Product
6.4.7.1.2 By Application
6.5 Middle East & Africa
6.5.1 Market Size & Forecast (Value & Volume)
6.5.2 Saudi Arabia
6.5.2.1.1 By Product
6.5.2.1.2 By Application
6.5.3 South Africa
6.5.3.1.1 By Product
6.5.3.1.2 By Application
6.5.4 Kwait
6.5.4.1.1 By Product
6.5.4.1.2 By Application
6.5.5 Rest of Middle East & Africa
6.5.5.1.1 By Product
6.5.5.1.2 By Application
7 Company Profile
7.1 Thermo Fisher Scientific Inc
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Recent Developments
7.1.4 Product Portfolio
7.2 Atlanta Biologicals Inc.
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Recent Developments
7.2.4 Product Portfolio
7.3 Tissue Culture Biologicals
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Recent Developments
7.3.4 Product Portfolio
7.4 HiMedia Laboratories
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Recent Developments
7.4.4 Product Portfolio
7.5 Bovogen Biologicals Pty Ltd.
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Recent Developments
7.5.4 Product Portfolio
7.6 TCS Biosciences Ltd.
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Recent Developments
7.6.4 Product Portfolio
7.7 Rocky Mountain Biologicals
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Recent Developments
7.7.4 Product Portfolio
7.8 GE Healthcare
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Recent Developments
7.8.4 Product Portfolio
7.9 PAN-Biotech
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Recent Developments
7.9.4 Product Portfolio
TABLE 1 Global Fetal bovine serum Market Share, By Product, 2015 – 2026 ($Million)
TABLE 2 Charcoal Stripped Fetal bovine serum Market Share, By Region, 2015 – 2026 ($ Million)
TABLE 3 Dialyzed Fetal Bovine Serum (FBS) Fetal bovine serum Market Share, By Region, 2015 – 2026 ($ Million)
TABLE 4 Chromatographic Fetal bovine serum Market Share, By Region, 2015 – 2026, ($ Million)
TABLE 5 Stem Cell Fetal bovine serum Market Share, By Region, 2015 – 2026, ($ Million)
TABLE 6 Global Fetal bovine serum Market Share, By Application, 2015 – 2026 ($Million)
TABLE 7 Global Fetal bovine serum Market through Indirect, By Region, 2015 – 2026 ($ Million)
TABLE 8 Global Fetal bovine serum Market Share Value, 2015 – 2026 ($Million)
TABLE 9 America Fetal bovine serum Market Share Value, By Country, 2015 – 2026 ($Million)
TABLE 10 America Fetal bovine serum Market Share value, By Product, 2015-2026 ($Million)
TABLE 11 America Fetal bovine serum Market Share value, By Application, 2015-2026 ($Million)
TABLE 12 U.S. Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 13 U.S. Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 14 Canada Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 15 Canada Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 16 Mexico Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 17 Mexico Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 18 Latin America Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 19 Latin America Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 20 Europe Fetal bovine serum Market Share Value, By Country, 2015 – 2026 ($Million)
TABLE 21 Europe Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 22 Europe Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 23 Germany Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 24 Germany Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 25 France Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 26 France Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 27 UK Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 28 UK Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 29 Italy Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 30 Italy Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 31 Spain Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 32 Spain Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 33 Rest of Europe Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 34 Rest of Europe Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 35 Asia-Pacific Fetal bovine serum Market Share Value, By Country, 2015 – 2026 ($Million)
TABLE 36 Asia-Pacific Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 37 Asia-Pacific Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 38 Japan Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 39 Japan Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 40 China Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 41 China Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 42 Australia Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 43 Australia Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 44 India Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 45 India Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 46 South Korea Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 47 South Korea Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 48 Rest of Asia-pacific Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 49 Rest of Asia-pacific Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 50 LAMEA Fetal bovine serum Market Share Value, By Country, 2015 – 2026 ($Million)
TABLE 51 LAMEA Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 52 LAMEA Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 53 Saudi Arabia Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 54 Saudi Arabia Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 55 Saudi Arabia Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 56 Saudi Arabia Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 57 South Africa Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 58 South Africa Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 59 South Africa Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 60 South Africa Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 61 South Africa Fetal bovine serum Market share, By End User, 2015-2026 ($Million)
TABLE 62 South Africa Fetal bovine serum Market share, By End User, 2015-2026 ($Million)
TABLE 63 Brazil Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 64 Brazil Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 65 Brazil Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 66 Brazil Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 67 Rest of LAMEA Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 68 Rest of LAMEA Fetal bovine serum Market share, By Product, 2015-2026 ($Million)
TABLE 69 Rest of LAMEA Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
TABLE 70 Rest of LAMEA Fetal bovine serum Market share, By Application, 2015-2026 ($Million)
List of Figures
FIGURE 1 Global Fetal bovine serum Market Overview
FIGURE 2 Value Chain Analysis
FIGURE 3 Bargaining Power of Suppliers
FIGURE 4 Bargaining Power of Buyers
FIGURE 5 Threat of Substitutes
FIGURE 6 Threat of New Entrants
FIGURE 7 Competitive Rivalry
FIGURE 8 Fetal bovine serum Market, Market Share Analysis, 2016
FIGURE 9 Global Fetal bovine serum Market, 2015-2026
FIGURE 10 U.S. Fetal bovine serum Market Share, 2017-2026 ($Million)
FIGURE 11 Canada Fetal bovine serum Market Share, 2017-2026 ($Million)
FIGURE 12 Mexico Fetal bovine serum Market Share, 2017-2026 ($Million)
FIGURE 13 Germany Fetal bovine serum Market Share, 2017-2026 ($Million)
FIGURE 14 France Fetal bovine serum Market Share, 2017-2026 ($Million)
FIGURE 15 UK Fetal bovine serum Market Share, 2017-2026 ($Million)
FIGURE 16 Italy Fetal bovine serum Market Share, 2017-2026 ($Million)
FIGURE 17 Spain Fetal bovine serum Market Share, 2017-2026 ($Million)
FIGURE 18 REST OF EUROPE Fetal bovine serum Market Share, 2017-2026 ($Million)
FIGURE 19 Japan Fetal bovine serum Market Share, 2017-2026 ($Million)
FIGURE 20 China Fetal bovine serum Market Share, 2017-2026 ($Million)
FIGURE 21 Australia Fetal bovine serum Market Share, 2017-2026 ($Million)
FIGURE 22 India Fetal bovine serum Market Share, 2017-2026 ($Million)
FIGURE 23 South Korea Fetal bovine serum Market Share, 2017-2026 ($Million)
FIGURE 24 Rest of Asia-pacific Fetal bovine serum Market Share, 2017-2026 ($Million)
FIGURE 25 Saudi Arabia Fetal bovine serum Market Share, 2017-2026 ($Million)
FIGURE 26 South Africa Fetal bovine serum Market Share, 2017-2026 ($Million)
FIGURE 27 Brazil Fetal bovine serum Market Share, 2017-2026 ($Million)
FIGURE 28 Rest of LAMEA Fetal bovine serum Market Share, 2017-2026 ($Million)
FIGURE 29 Thermo Fisher Scientific Inc.: Revenue Analysis, ($ million)
FIGURE 30 Thermo Fisher Scientific Inc.: Segment Revenue 2017 (%)